Skip to main content
Be The Investor
S&P 500
7,623.68-0.52%
After Hours7,591.77-0.42%
Nasdaq Composite
25,955.34-0.21%
After Hours25,987.40+0.12%
Dow Jones
52,215.16-1.23%
After Hours51,551.99-1.27%
Russell 2000
2,775.90-0.29%
After Hours2,764.38-0.41%
VIX
VIX
19.45+2.21%
Bitcoin
80,321.79-0.56%
Ethereum
2,328.27-1.17%
Solana
100.73-1.51%
Gold
4,007.90-1.29%
Silver
53.95-1.92%
Copper
6.508+1.71%
WTI Crude Oil
103.27+3.82%
US 10-Year Treasury Yield
4.988+0.71%
Home›Stocks›CKPT
OverviewChartNewsFinancialsBusiness ModelCompetitorsStatisticsAnalysisEarningsValuationHoldersOptionsInsidersForecastCompareFAQ
CKPT

Checkpoint Therapeutics, Inc.

CKPT
NASDAQUnited States flagUSReal-Time Price
$4.26USD
0.00 (0.00%)Today
BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
Valuation unavailable
High Risk

Checkpoint Therapeutics, Inc. (CKPT) Valuation

Is Checkpoint Therapeutics, Inc. (CKPT) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.

Valuation Snapshot

P/E (TTM)
Trailing Price-to-Earnings
—
Forward P/E
Next 12 months estimate
—
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
—
Revenue Growth
Year-over-year
—

Valuation Risk

Checkpoint Therapeutics, Inc.'s valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.

Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for CKPT